Abstract

Comparison of P53 mutation status, primary cytoreductive surgical outcomes, and overall survival in patients with ovarian cancer

Authors: David Engle (University of Iowa) , Hubert Fornalik (University of Iowa) , Traci Neff (University of Iowa) , Anna Button (University of Iowa) , K Collins (University of Iowa) , Amina Ahmed (University of Iowa) , David Bender (University of Iowa) , Susan Lutgendorf (University of Iowa) , Michael Goodheart

Abstract

Optimal surgical cytoreduction continues to be an important prognostic variable in patients with ovarian cancer independent of p53 mutational status. Among patients with suboptimal cytoreduction a p53 mutation may offer a survival advantage.

Keywords: P53, cytoreductive surgery, survival, ovarian cancer

How to Cite: Engle, D. , Fornalik, H. , Neff, T. , Button, A. , Collins, K. , Ahmed, A. , Bender, D. , Lutgendorf, S. & Goodheart, M. (2011) “Comparison of P53 mutation status, primary cytoreductive surgical outcomes, and overall survival in patients with ovarian cancer”, Proceedings in Obstetrics and Gynecology. 2(1). doi: https://doi.org/10.17077/2154-4751.1107